Lundemose Anker Md, Ph.D, Dsc
EVP, Corp. Dev & Strategic Pln
Avg. Two Year Performance
No Purchase Track Record
(< 1%) Avg. Sale Return
0% Compound
Holdings: 0 shares
Last Three Months: 27-Aug-24 -- 26-Nov-24
Sentiment
Company Sentiment
Biotechnology
Drugs
Two Year Chart
27-Nov-22 -- 26-Nov-24
Price ($)
Sentiment
Company Sentiment
Most Recent Insider Transactions